Log In
Print
BCIQ
Print
Print this Print this
 

SeHCAT

  Manage Alerts
Collapse Summary General Information
Company General Electric Co.
DescriptionSelenium-labeled synthetic bile salt
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGastrointestinal, Diagnostic
Indication DetailsDiagnose bile acid malabsorption in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today